Moody’s affirms ‘Baa2’ rating for Virginia Mason Medical Center

Moody’s Investors Service has affirmed its “Baa2” rating for Seattle-based Virginia Mason Medical Center, affecting $393 million of debt.

Advertisement

The affirmation reflects Virginia Mason’s unique value proposition, which consists of a physician-oriented operating culture and a high-acuity mix of services. The hospital has a history of suppressed margins due to the large number of employed physicians.

The rating outlook has been revised from stable to negative.

More articles on healthcare finance:

Partners posts $463M loss in Q1
Tennessee hospital receives court oversight amid financial troubles
Carilion Clinic CFO Don Halliwill’s advice to other finance execs: ‘Hire people who are smarter and more talented than you’

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.